Cohort Profile: The French E3N Cohort Study
Open Access
- 10 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 44 (3), 801-809
- https://doi.org/10.1093/ije/dyu184
Abstract
The E3N (Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l'Education Nationale) cohort was initiated in 1990 to investigate therisk factors associated with cancer and other major non-communicable diseases in women. The participants were insured through a national health system that primarily covered teachers, and were enrolled from 1990 after returning baseline self-administered questionnaires and providing informed consent. The cohort comprised nearly 100 000 women with baseline ages ranging from 40 to 65 years. Follow-up questionnaires were sent approximately every 2–3 years after the baseline and addressed general and lifestyle characteristics together with medical events (cancer, cardiovascular diseases, diabetes, depression, fractures and asthma, among others). The follow-up questionnaire response rate remained stable at approximately 80%. A biological material bank was generated and included blood samples collected from 25 000 women and saliva samples from an additional 47 000 women. Ageing among the E3N cohort provided the opportunity to investigate factors related to age-related diseases and conditions as well as disease survival. The new E4N complementary cohort (Epidemiology 4 kNowledge), which comprises the children and grandchildren of the E3N cohort as well as the children’s fathers, will allow researchers to investigate key life periods during which exposures to environmental factors most strongly influence the later disease risk. The E3N and E4N cohort data will be used to investigate diseases and risk factors through a transgenerational approach. Requests for collaborations are welcome, particularly those in conjunction with rare diseases.Keywords
This publication has 33 references indexed in Scilit:
- Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008American Journal of Epidemiology, 2014
- Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohortBreast Cancer Research and Treatment, 2014
- Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 2011
- Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?Journal of Clinical Oncology, 2009
- Breast Cancer and Hormonal Therapy in Postmenopausal WomenThe New England Journal of Medicine, 2009
- Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast CancerJournal of Clinical Oncology, 2008
- Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyBreast Cancer Research and Treatment, 2007
- Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohortInternational Journal of Cancer, 2004
- Anthropometric Measurements and Body Silhouette of WomenJournal of the American Dietetic Association, 2002
- A validation study on status and age of natural menopause reported in the E3N cohortMaturitas, 1998